-
Technology
-
Industry
-
Solutions
-
- ASSET MANAGEMENT
- CUSTOMER EXPERIENCE MANAGEMENT
- CYBER SECURITY
- DATA CENTER
- DOCUMENT MANAGEMENT
- ELECTRONIC DATA INTERCHANGE
- ENTERPRISE DATA MANAGEMENT
- ENTERPRISE RESOURCE PLANNING
- ENTERPRISE RISK MANAGEMENT
- ENTERPRISE-GRADE WEB DATA SOLUTIONS
- FACILITY MANAGEMENT
- FIELD SERVICE
- IDENTITY AND ACCESS MANAGEMENT
- INFRASTRUCTURE
- IT SERVICE MANAGEMENT
- MANAGED IT SERVICES
- PAYMENT AND CARD
- PROJECT MANAGEMENT
- SOFTWARE TESTING
- STORAGE
- VIDEO SOLUTIONS
- WORKFLOW
-
-
Platforms
-
Functions
- Leadership Perspectives
- Innovation Insights
- Research
- Magazines
- News
- CXO Awards
Dr. Anthony Chang, FounderDr. Chang is the chief intelligence and innovation officer (CIIO) at Children’s Hospital of Orange County. He also has a background in Artificial Intelligence with an MS in Biomedical Data Science from Stanford School of Medicine. Alongside MI10, he founded AIMed, a company that organizes events worldwide about the application of AI in medicine and healthcare. As a convener of hospital and healthcare organizations, companies with AI services, and investors in the space, Dr. Chang has a unique perspective of being in the epicentre of AI in medicine and healthcare. He realized there was a need for education, consultation, and strategy with regard to AI implementation in medicine and healthcare. Based on this need, the idea for MI10 was conceptualized. MI10 serves as an informed and connected matchmaker for all stakeholders, which include hospitals and healthcare organizations, companies and startups with AI services and investors.
MI10 continually assesses healthcare organizations and AI companies by using a proprietary 11-dimension scoring tool to determine an organization’s or company’s AI capabilities.
MI10 continually assesses hospitals and companies by using a proprietary 11-dimension scoring tool to determine an organization’s or company’s AI capabilities
After the final score (0-100 points) is calculated by measuring various metrics, MI10 can then help its clients formulate an AI strategy and elaborate different methods to improve their score. An essential part of guiding an organization to improve its AI capabilities involves MI10 providing on-site educational services as well as real-time consultations. They will also offer public monthly seminars on a wide variety of AI-related topics. In addition, MI10 is developing an online video series to educate its clients in the domain of AI in medicine and healthcare. The preliminary plan is to develop 25- 30 learning modules that cover various topics in AI in medicine and healthcare. Dr. Chang explains that MI10 helps any healthcare organization as well as company through its cultural transformation process for artificial intelligence adoption.
Recently, MI10 entered into a long-term collaboration with a hospital in the U.S. to help them improve their capability to adopt AI solutions. After completing an on-site assessment, MI10 is now pursuing deployment and strategy formulation to enhance the hospital’s AI capabilities. Based on the MI10 scoring tool, Dr. Chang notes that most hospitals score relatively low (in the 20-60 out of 100 range). Additionally, MI10 also plans to score AI in medicine and healthcare companies with higher-scoring ones to be recommended to hospitals and healthcare organizations needing AI services. Lastly, MI10 is also available to guide companies and startups offering AI services to improve their clinical relevance and eventual success.
MI10 and Deloitte China Announce Strategic Cooperation
Thursday, August 10, 2023
MI10 and Deloitte Consulting China are proud to announce a strategic cooperation to bring artificial intelligence consulting services to clients in the healthcare sector. Through this cooperation, the two organizations will offer strategy and education to more successfully implement AI solutions and better serve patients and healthcare stakeholders.
Deloitte China offers a full range of audit & assurance, consulting, financial advisory, risk advisory and tax services to local, multinational and growth enterprise clients in China.
MI10 is a physician-led artificial intelligence strategy and education advisory firm.
Anthony Chang
After his cardiology training at the Children’s Hospital of Philadelphia with his research interest in mathematics and chaos theory in biomedicine, Dr. Anthony Chang was an attending cardiologist in the cardiovascular intensive care unit of Boston Children’s Hospital and an assistant professor at Harvard Medical School. Throughout his career as a pediatric cardiac intensive care physician, he has been interested in applications of biomedical data to decision-making. He completed his Masters of Science (MS) in Data Science with a sub-specialization in artificial intelligence from Stanford School of Medicine. He is also a computer scientist-in-residence at Chapman University. He is currently the Chief Intelligence and Innovation Officer and Medical Director of the Heart Failure Program at Children’s Hospital of Orange County. He is the founder and medical director of the Medical Intelligence and Innovation Institute (MI3) that is supported by the Sharon Disney Lund Foundation. The institute, founded in 2015, is dedicated to the introduction and implementation of artificial intelligence in medicine and was the first institute of its kind in a hospital. He intends to build a clinician-computer scientist interface with a nascent society (the Medical Intelligence Society) and is the editor-in-chief of Intelligence-based Medicine, the accompanying journal for his book, Intelligence-Based Medicine: Artificial Intelligence and Human Cognition in Clinical Medicine and Healthcare. He is the organizing chair for Artificial Intelligence in Medicine (AIMed) meetings around the world, the largest and most comprehensive clinician-led meetings that focus on applications of artificial intelligence in medicine and the dean of the nascent American Board of Artificial Intelligence in Medicine (ABAIM).
Company
MI10
Management
Dr. Anthony Chang, Founder
Description
Medical Intelligence 10 (MI10), an AI-inspired education, advisory, and consulting firm, is on a mission to remove the barriers preventing healthcare organizations from entering successful partnerships with AI companies. MI10 helps its clients attain the highest possible returns for any investment or expenditure in AI. The company assists executiveleaders and physicians as well as their investors in the evaluation and implementation of AI strategies in healthcare organizations. This also involves an assessment of cybersecurity postures in a healthcare system. MI10 performs an assessment using a proprietary 11-dimension scoring tool to determine an organization’s AI readiness to enter into an AI-healthcare partnership
